Screening for prostate cancer. The case against.

Screening for prostate cancer. The case against.

Bibliographic Details
Main Authors:	Donovan, J, Hamdy, F, Neal, D
Format:	Journal article
Language:	English
Published:	2005

Similar Items

Prostate cancer: screening approaches.
by: Donovan, J, et al.
Published: (2005)

Prostate cancer: screening approaches
by: Donovan, J, et al.
Published: (2005)

Screening for prostate cancer remains controversial.
by: Neal, D, et al.
Published: (2009)

The protect (prostate testing for cancer and treatment) study: Advanced cases found through a UK screening study
by: Neal, D, et al.
Published: (2006)

The protecT (prostate testing for cancer and treatment) study: Evaluating screening and treatment of clinically localised prostate cancer in the UK
by: Hamdy, F, et al.
Published: (2006)

10-year outcomes in localized prostate cancer.
by: Hamdy, F, et al.
Published: (2017)

The case against.
by: Donovan, J, et al.
Published: (2005)

10-year outcomes in localized prostate cancer: Authors' reply
by: Hamdy, F, et al.
Published: (2017)

Latest results from the UK trials evaluating prostate cancer screening and treatment: the CAP and ProtecT studies.
by: Lane, J, et al.
Published: (2010)

Prostate cancer detection in men aged 45-49 years in the UK protect (prostate testing for cancer and treatment) trial
by: Hamdy, F, et al.
Published: (2006)

Predictors of attendance for prostate-specific antigen screening tests and prostate biopsy.
by: Avery, K, et al.
Published: (2012)

Predictors of attendance for prostate-specific antigen screening tests and prostate biopsy
by: Avery, K, et al.
Published: (2012)

Estimating the sensitivity of a prostate cancer screening programme for different PSA cut-off levels: A UK case study
by: Leal, J, et al.
Published: (2018)

Screen-detected prostate cancer and the insulin-like growth factor (IGF)-axis: Results of a case-control study
by: Oliver, SE, et al.
Published: (2002)

Association of diabetes mellitus with prostate cancer: nested case-control study (Prostate testing for cancer and treatment study).
by: Turner, E, et al.
Published: (2011)

Screen-detected prostate cancer and the insulin-like growth factor axis: results of a population-based case-control study.
by: Oliver, SE, et al.
Published: (2004)

Screening for prostate cancer: an update.
by: Bryant, R, et al.
Published: (2008)

Alcohol consumption and PSA-detected prostate cancer risk--a case-control nested in the ProtecT study.
by: Zuccolo, L, et al.
Published: (2013)

THE PROTECT TRIAL - EVALUATING THE EFFECTIVENESS OF TREATMENTS FOR CLINICALLY LOCALISED PROSTATE CANCER
by: Lane, J, et al.
Published: (2009)

The protect trial - Evaluating the effectiveness of treatments for clinically localised prostate cancer and associated molecular and genetic epidemiology studies
by: Lane, J, et al.
Published: (2007)

Ethics of clinical trials from bayesian perspective: randomisation to clinical trials may solve dilemma of treatment choice in prostate cancer.
by: Hamdy, F, et al.
Published: (2003)

The ProtecT trial - Evaluating the effectiveness of treatment for clinically localised prostate cancer (ISRCTN20141297)
by: Lane, J, et al.
Published: (2004)

Measurement of insulin-like growth factor axis does not enhance specificity of PSA-based prostate cancer screening.
by: Oliver, SE, et al.
Published: (2004)

ASSOCIATIONS OF SEXUAL DYSFUNCTION WITH LOCALIZED AND ADVANCED PROSTATE CANCER: A CASE-CONTROL STUDY NESTED WITHIN THE UK POPULATION-BASED PROTECT (PROSTATE TESTING FOR CANCER AND TREATMENT) STUDY
by: Collin, S, et al.
Published: (2009)

Do the risk factors of age, family history of prostate cancer or a higher prostate specific antigen level raise anxiety at prostate biopsy?
by: Macefield, R, et al.
Published: (2009)

Measuring the psychosocial impact of population-based prostate-specific antigen testing for prostate cancer in the UK.
by: Brindle, L, et al.
Published: (2006)

Measurement of the insulin-like growth factor (IGF)-axis does not enhance the specificity of PSA-based prostate cancer screening.
by: Oliver, SE, et al.
Published: (2002)

Time for a “radical” change to active surveillance for prostate cancer?
by: Donovan, J, et al.
Published: (2018)

ASSOCIATION OF ANTHROPOMETRIC AND LIFESTYLE FACTORS WITH PROSTATE SPECIFIC ANTIGEN (PSA) TRAJECTORIES IN MEN WITH LOCALISED PROSTATE CANCER UNDERGOING ACTIVE MONITORING
by: Burton, A, et al.
Published: (2011)

Screening for prostate cancer: views from the UK and the rest of the world
by: Hamdy, F
Published: (2003)

Associations of sexual dysfunction symptoms with PSA-detected localised and advanced prostate cancer: a case-control study nested within the UK population-based ProtecT (Prostate testing for cancer and Treatment) study.
by: Collin, S, et al.
Published: (2009)

Importance of prostate volume in the European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators: results from the prostate biopsy collaborative group.
by: Roobol, M, et al.
Published: (2012)

Patient-reported outcomes following treatment for localized prostate cancer: Helping decision making for patients and their physicians.
by: Hamdy, F, et al.
Published: (2017)

Population-based prostate-specific antigen testing in the UK leads to a stage migration of prostate cancer.
by: Moore, A, et al.
Published: (2009)

Diagnostic pathways for screen-detected prostate cancer: The plot thickens
by: Hamdy, F, et al.
Published: (2017)

Associations of adiponectin and leptin with stage and grade of PSA-detected prostate cancer: the ProtecT study.
by: Burton, A, et al.
Published: (2013)

Caspase-8 gene SNPs in prostate cancer susceptibility a replication study
by: Parry, M, et al.
Published: (2010)

Diagnosis, management and screening of early localised prostate cancer.
by: Selley, et al.
Published: (1997-01-01)

Association of obesity with prostate cancer: A case-control study within the population-based PSA testing phase of the ProtecT study
by: Dimitropoulou, P, et al.
Published: (2011)

Association of obesity with prostate cancer: a case-control study within the population-based PSA testing phase of the ProtecT study.
by: Dimitropoulou, P, et al.
Published: (2011)